Interestingly, growing evidence suggests that dysregulation of APC/C-CDH1 is involved in neurodegenerative diseases, potentially as a consequence of amyloid-β driven proteasome-dependent degradation of CDH1 [50]. Here, CDH1 is linked to neurodegenerative disease.